All In Biotech

Drug Trial Radar · NCT00675922

Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks

Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds

Last checked: Nov 20, 2026Latest source record: Jun 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

98

Actual

Start

Jul 1995

Primary completion

May 2008

Study completion May 2008

Sponsor

Lead sponsor
The University of Texas Medical Branch, GalvestonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 12, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 day, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).

Conditions

  • Burn

Interventions

  • Sulfamylon 5% and Silver Nitrate SoaksDrug

    Application of Sulfamylon and Silver Nitrate Solution to burn wound daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infection RateTime frame: Acute hospitalization following burn injury: admission to discharge (1-20 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Texas Medical Branch

    Galveston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.